Illumina is suing Element Biosciences, with the sequencing giant accusing its smaller rival of infringing on five of its patents covering flow cell and imaging technologies used in automated genetic sequencing, and Element vowing to defend itself in court. In a complaint filed Thursday in U.S. District Court for the District of Delaware, Illumina and